Abbott India

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE358A01014
  • NSEID: ABBOTINDIA
  • BSEID: 500488
INR
27,415.00
135 (0.49%)
BSENSE

May 14

BSE+NSE Vol: 7.63 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -0.84% vs -1.88% in Dec 2025

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 5.05% vs -9.47% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 3.75% vs -7.71% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 12.04% vs -27.42% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Abbott India With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,709.51
2,328.23
-618.72
-26.57%
Other Operating Income
0.00
31.70
-31.70
-100.00%
Total Operating income
1,709.51
2,359.93
-650.42
-27.56%
Raw Material Cost
157.80
709.60
-551.80
-77.76%
Purchase of Finished goods
809.54
104.66
704.88
673.50%
(Increase) / Decrease In Stocks
-62.30
56.77
-119.07
-209.74%
Employee Cost
145.76
466.95
-321.19
-68.78%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
177.86
526.25
-348.39
-66.20%
Total Expenditure (Excl Depreciation)
1,228.66
1,864.23
-635.57
-34.09%
Operating Profit (PBDIT) excl Other Income
480.85
495.70
-14.85
-3.00%
Other Income
75.59
109.06
-33.47
-30.69%
Operating Profit (PBDIT)
556.44
604.76
-48.32
-7.99%
Interest
6.14
21.98
-15.84
-72.07%
Exceptional Items
0.00
-177.07
177.07
100.00%
Gross Profit (PBDT)
550.30
405.71
144.59
35.64%
Depreciation
19.07
59.18
-40.11
-67.78%
Profit Before Tax
531.23
346.53
184.70
53.30%
Tax
136.30
64.46
71.84
111.45%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
394.93
282.07
112.86
40.01%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
394.93
282.07
112.86
40.01%
Equity Capital
21.25
28.22
-6.97
-24.70%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
185.85
10.00
175.85
1,758.50%
Diluted Earnings per share
185.85
9.99
175.86
1,760.36%
Operating Profit Margin (Excl OI)
28.13%
21.29%
0.00
6.84%
Gross Profit Margin
32.19%
17.43%
0.00
14.76%
PAT Margin
23.10%
12.12%
0.00
10.98%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,709.51 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -0.84% vs -1.88% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 6.54% vs 11.54% in Mar 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 394.93 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 5.05% vs -9.47% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 7.60% vs 27.86% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 480.85 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 3.75% vs -7.71% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 12.21% vs 30.05% in Mar 2025

Quarterly - Interest
Interest 6.14 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 12.04% vs -27.42% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 56.63% vs 39.50% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.13%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025